Ipamorelin 10mg
99.3% HPLC PurityA selective pentapeptide growth-hormone secretagogue (GHRP).

SKU: PW-028 • Batch: PW-260312
Long-acting GHRH analogue incorporating a Drug Affinity Complex (DAC) for extended half-life research, supplied as a 10mg vial at 99% HPLC purity.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
A selective pentapeptide growth-hormone secretagogue (GHRP).
A stabilised analogue of growth-hormone-releasing hormone (GHRH).
A GHRH analogue paired with a GHRP in one vial, studied in growth-hormone research.
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
CJC-1295 with DAC is a modified analogue of growth hormone-releasing hormone (GHRH), supplied here on its own rather than blended with a GHRP. The Drug Affinity Complex (DAC) modification covalently binds the peptide to serum albumin after administration, which greatly extends its circulating half-life relative to native GHRH or to CJC-1295 without DAC (sometimes sold as Mod GRF 1-29).
That extended half-life is the reason researchers select the DAC form: where the non-DAC variant clears within hours, the DAC-modified peptide remains measurable in circulation for days, which changes the sampling design a protocol needs.
Supplied as a lyophilised powder at 99% HPLC purity with full Certificate of Analysis documentation — independent third-party HPLC testing, mass spectrometry identity confirmation, LAL endotoxin assay (<1.0 EU/mg), and sterility screening before dispatch.
The DAC (Drug Affinity Complex) modification binds the peptide to serum albumin, extending its circulating half-life from hours to days. CJC-1295 without DAC — often sold as Mod GRF 1-29 — clears far more quickly. This product is the DAC-modified form.
This vial contains CJC-1295 with DAC only. The blend pairs it with Ipamorelin, a selective GHRP, in the same vial. Which one suits a protocol depends on whether the research design calls for the GHRH analogue alone or the two-compound combination.
Add 2–3mL of bacteriostatic water slowly to the vial. Gently swirl; do not shake. Allow the lyophilised powder to dissolve completely before use in research protocols.
Store lyophilised at −20°C for long-term stability. Once reconstituted, store at 2–8°C and use within 4 weeks. Avoid repeated freeze-thaw cycles.
CJC-1295 (with DAC) 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.